Levetiracetam is an antiseizure medicine that compounding pharmacies prepare by prescription.
Levetiracetam is an antiseizure (antiepileptic) drug that is chemically unrelated to other antiseizure drugs. Its exact mechanism is unknown, but it binds synaptic vesicle protein 2A (SV2A), which helps regulate the release of neurotransmitters, and that binding appears to contribute to its antiseizure action. Keppra (levetiracetam tablets and oral solution) is FDA-approved for partial-onset seizures in patients 1 month and older, and as add-on therapy for myoclonic seizures in juvenile myoclonic epilepsy (age 12 and older) and for primary generalized tonic-clonic seizures in idiopathic generalized epilepsy (age 6 and older). Keppra injection, Keppra XR extended-release tablets and many generics are also manufactured. A prescriber might order levetiracetam compounded in a strength, flavor or vehicle that is not manufactured, or without certain excipients. Compounded preparations are not FDA-approved and require a prescription.
Keppra has no boxed warning. It can cause behavior changes such as aggression, irritability, anxiety and depression, and less often psychotic symptoms; like other antiseizure drugs, it raises the risk of suicidal thoughts or behavior. Sleepiness, fatigue and poor coordination can affect driving. Serious reactions include anaphylaxis and angioedema, Stevens-Johnson syndrome and toxic epidermal necrolysis, DRESS and blood count changes. Do not use it if you are allergic to it, and do not stop it suddenly. It has few drug interactions, but kidney impairment requires dose adjustment. In children under 4, diastolic blood pressure can rise. The label reports no drug-associated increase in major birth defects, and blood levels can fall during pregnancy. LactMed notes it can occasionally sedate the breastfed infant and is not necessarily a reason to stop breastfeeding. Talk to your prescriber or pharmacist about mood changes, rash or other side effects.
Levetiracetam binds SV2A, a synaptic vesicle protein involved in exocytosis; among analogs, SV2A affinity correlated with antiseizure potency in animal models. Per the Keppra label, oral bioavailability is 100%, peak concentrations occur in about an hour, tablets and oral solution are bioequivalent, kinetics are linear, and protein binding is under 10%. Metabolism is by enzymatic hydrolysis of the acetamide group without CYP involvement; adult half-life is about 7 hours, longer in older adults, and 66% of a dose is excreted unchanged in urine. Clearance tracks creatinine clearance, so renal dose adjustment and supplemental doses after dialysis are recommended. Labeled indications: partial-onset seizures from 1 month of age; adjunctive therapy for myoclonic seizures in juvenile myoclonic epilepsy and for primary generalized tonic-clonic seizures. StatPearls lists off-label use in status epilepticus, seizure prophylaxis after subarachnoid hemorrhage, traumatic brain injury and supratentorial neurosurgery, and seizures in palliative care; these are not FDA-approved indications. Check baseline creatinine; monitor mood, suicidality and psychosis, and blood pressure in children under 4. Routine drug level monitoring is not recommended but may help in critically ill, pregnant or elderly patients. Withdraw gradually. Dosing is per prescriber. Levetiracetam is not a controlled substance.
Compounded at Bayview
Patient guides for the preparations we make most often. Each one is compounded to order and requires a prescription.
We do not have a patient page for this ingredient yet. That does not mean we cannot make it. Bayview compounds this ingredient to a prescriber's order, and our full compounding formulary lists every preparation we make. Viewing the formulary requires a prescriber account.
Prescriber sign inFor prescribers
Every preparation in our formulary that contains this ingredient. Strength, base and dose form are set by the prescription.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.